CI
45
2
FRT
45
2
ESS
33
2
PH
60
-2
MDLZ
34
4
LYB
44
3
INTC
61
5
CLX
42
-3
PNW
69
2
HPE
63
4
PG
20
-2
AMGN
39
-5
DAL
66
-2
HSY
53
3
MAT
30
-2
PCG
54
-4
TAP
35
4
PEP
56
3
EQR
25
5
ECL
59
-3
CI
45
2
FRT
45
2
ESS
33
2
PH
60
-2
MDLZ
34
4
LYB
44
3
INTC
61
5
CLX
42
-3
PNW
69
2
HPE
63
4
PG
20
-2
AMGN
39
-5
DAL
66
-2
HSY
53
3
MAT
30
-2
PCG
54
-4
TAP
35
4
PEP
56
3
EQR
25
5
ECL
59
-3
Financhill
Back

Range Nuclear Renaissance Index ETF Vs. Novo Nordisk A/S Industry Stock Comparison

Buy
53

NUKZ
Range Nuclear Renaissance Index ETF

Last Price:
$67.09
Seasonality Move:
22.67%
Sell
17

NONOF
Novo Nordisk A/S

Last Price:
$35.59
Seasonality Move:
4.8%
Buy
53
Range Nuclear Renaissance Index ETF (NUKZ) is a Buy

Is Range Nuclear Renaissance Index ETF a Buy, Sell or Hold?

  • The current Range Nuclear Renaissance Index ETF [NUKZ] share price is $67.00. The Score for NUKZ is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • NUKZ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
17
Novo Nordisk A/S (NONOF) is a Sell

Is Novo Nordisk A/S a Buy, Sell or Hold?

  • The current Novo Nordisk A/S [NONOF] share price is $35.59. The Score for NONOF is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

NUKZ Stock Price Chart

What is Range Nuclear Renaissance Index ETF's stock price today?

  • The Range Nuclear Renaissance Index ETF share price today is $67.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUKZ is experiencing buying pressure, which is a positive indicator for future bullish movement.

NONOF Stock Price Chart

What is Novo Nordisk A/S's stock price today?

  • The Novo Nordisk A/S share price today is $35.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight selling pressure.

NUKZ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.14 Sell
Relative Strength Index (14 RSI): 46.68 Sell
Chaikin Money Flow: 31264 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.02 - 70.9) Sell
Bollinger Bands (100): (65.22 - 70.92) Sell

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.13 Sell
Relative Strength Index (14 RSI): 34 Sell
Chaikin Money Flow: -84014 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.94 - 38.44) Sell
Bollinger Bands (100): (39.64 - 55.38) Sell

NUKZ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.25 Buy
20-day SMA: 67.61 Sell
50-day SMA: 69.75 Sell
200-day SMA: 65.1 Buy
8-day EMA: 66.47 Buy
20-day EMA: 67.55 Sell
50-day EMA: 68.57 Sell
200-day EMA: 63.73 Buy

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.83 Sell
20-day SMA: 37 Sell
50-day SMA: 44.15 Sell
200-day SMA: 53.01 Sell
8-day EMA: 35.83 Sell
20-day EMA: 37.34 Sell
50-day EMA: 41.96 Sell
200-day EMA: 54.32 Sell

Range Nuclear Renaissance Index ETF Earnings Growth & NUKZ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Range Nuclear Renaissance Index ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk A/S Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):